New T-Rex ancestor discovered in drawers of Mongolian institute
This slender ancestor of the massive Tyrannosaurus Rex was around four metres (13 feet) long and weighed three quarters of a tonne, according to a new study in the journal Nature.
"It would have been the size of a very large horse," study co-author Darla Zelenitsky of Canada's University of Calgary told AFP.
The fossils were first dug up in southeastern Mongolia in the early 1970s but at the time were identified as belonging to a different tyrannosaur, Alectrosaurus.
For half a century, the fossils sat in the drawers at the Institute of Paleontology of the Mongolian Academy of Sciences in the capital Ulaanbaatar.
Then PhD student Jared Voris, who was on a trip to Mongolia, started looking through the drawers and noticed something was wrong, Zelenitsky said.
It turned out the fossils were well-preserved, partial skeletons of two different individuals of a completely new species.
"It is quite possible that discoveries like this are sitting in other museums that just have not been recognised," Zelenitsky added.
- 'Messy' family history -
They named the new species Khankhuuluu mongoliensis, which roughly means the dragon prince of Mongolia because it is smaller than the "king" T-Rex.
Zelenitsky said the discovery "helped us clarify a lot about the family history of the tyrannosaur group because it was really messy previously".
The T-Rex represented the end of the family line.
It was the apex predator in North America until 66 million years ago, when an asteroid bigger than Mount Everest slammed into the Gulf of Mexico.
Three quarters of life on Earth was wiped out, including all the dinosaurs that did not evolve into birds.
Around 20 million years earlier, Khankhuuluu -- or another closely related family member -- is now believed to have migrated from Asia to North America using the land bridge that once connected Siberia and Alaska.
This led to tyrannosaurs evolving across North America.
Then one of these species is thought to have crossed back over to Asia, where two tyrannosaur subgroups emerged.
One was much smaller, weighing under a tonne, and was nicknamed Pinocchio rex for its long snout.
The other subgroup was huge and included behemoths like the Tarbosaurus, which was only a little smaller than the T-rex.
One of the gigantic dinosaurs then left Asia again for North America, eventually giving rise to the T-Rex, which dominated for just two million years -- until the asteroid struck.
dl/gil
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Engadget
2 hours ago
- Engadget
CRISPR can stop malaria spread by editing a single gene in mosquitos
CRISPR gene-editing therapy has shown great potential to treat and even cure diseases, but scientists are now discovering how it can be used to prevent them as well. A team of researchers found a way to edit a single gene in a mosquito that prevented it from transmitting malaria, according to a paper published in Nature . These genetically modified mosquitos could eventually be released into the wild, helping prevent some of the 600,000 malaria deaths that occur each year. Mosquitos infect up to 263 million people yearly with malaria and efforts to reduce their populations have stalled as late. That's because both the mosquitos and their parasites that spread malaria have developed resistance to insecticides and other drugs. Now, biologists from UC San Diego, Johns Hopkins and UC Berkeley universities have figured out a way to stop malarial transmission by changing a single amino acid in mosquitos. The altered mosquitos can still bite people with malaria and pick up parasites from their blood, but those can no longer be spread to others. The system uses CRISPR-Cas9 "scissors" to cut out an unwanted amino acid (allele) that transmits malaria and replace it with a benign version. The undesirable allele, called L224, helps parasites swim to a mosquito's salivary glands where they can then infect a person. The new amino acid, Q224, blocks two separate parasites from making it to the salivary glands, preventing infection in people or animals. "With a single, precise tweak, we've turned [a mosquito gene component] into a powerful shield that blocks multiple malaria parasite species and likely across diverse mosquito species and populations, paving the way for adaptable, real-world strategies to control this disease," said researcher George Dimopoulos from Johns Hopkins University. Unlike previous methods of malarial control, changing that key gene doesn't affect the health or reproduction capabilities of mosquitos. That allowed the researchers to create a technique for mosquito offspring to inherit the Q224 allele and spread it through their populations to stop malarial parasite transmission in its tracks. "We've harnessed nature's own genetic tools to turn mosquitoes into allies against malaria," Dimopoulos said. If you buy something through a link in this article, we may earn commission.
New York Post
3 hours ago
- New York Post
Llamas could help treat schizophrenia: study
Talk about a llama-zing discovery. They're known for their fluffy furs and sassy stares, but scientists have discovered that llamas may also be the key to treating schizophrenia. And this isn't even the first time this year that llamas have been at the heart of curing a scary health issue. Advertisement They're known for their fluffy furs and sassy stares, but it turns out llamas may also be the key to treating schizophrenia. Cavan for Adobe – In a mind-blowing new study, French researchers have developed a molecule from llama antibodies that could one day help patients with schizophrenia overcome cognitive deficits — a major hurdle that existing treatments fail to address. Scientists at the Institute of Functional Genomics in Montpellier have engineered what's called a nanobody — a tiny antibody fragment found in camelids like llamas — that can activate a specific glutamate receptor responsible for brain signaling. What's more, this molecule can cross the blood-brain barrier — a major challenge in drug development — and go straight to work on neural receptors when injected via a vein or muscle. Advertisement Researchers tested the llama-derived nanobody in two preclinical models of schizophrenia. Just one injection was enough to boost brainpower in mice, showing a clear and sustained improvement in cognitive function for up to a week. More research will be needed to see if this presents a promising new avenue of treatment for schizophrenia and, if so, whether or not this can be expanded to treat other psychiatric and neurodegenerative diseases. Advertisement The findings were published Wednesday in the journal Nature. Schizophrenia is a chronic mental disorder that affects how people perceive reality, leading to hallucinations, delusions, disorganized thinking and speech, paranoia and time gaps. elnariz – Schizophrenia is a chronic mental disorder that affects how people perceive reality, leading to hallucinations, delusions, disorganized thinking and speech, paranoia and time gaps. More than 200,000 people in the US are living with schizophrenia, for which there is no cure. Advertisement The cause of schizophrenia is still unknown, but research suggests a combination of genetic and environmental factors are likely to encourage its onset, which typically occurs between the ages of 16 and 30. Schizophrenia is primarily treated with antipsychotics, which target some of the more severe symptoms like hallucinations and delusions, but fail to do much for cognitive function. This new study offers hope for repairing cognition, as opposed to simply managing symptoms. 'In humans obviously we don't know [yet], but in mice yes, it is sufficient to treat most deficits of schizophrenia,' paper author and CNRS molecular biologist Jean-Philippe Pin told Newsweek. 'For development as a therapeutic tool, more safety and bioavailability studies are needed. Production of large quantities of high quality must be set up to start human studies. For these two possibilities, either a company takes up our project or we find investors to create a startup company.' Meanwhile, another study published last month found that llamas may also hold the secret weapon to curing COVID — and it's also in their nanobodies. 'This work provides a strong foundation for developing next-generation antibodies that could be vital in combating not only current but also future coronavirus threats,' said Dr. Xavier Saelens, senior author of the study and a principal investigator at the VIB-UGent Center for Medical Biotechnology in Belgium.
Fox News
6 hours ago
- Fox News
AI tech detects hidden heart disease doctors often miss
You might think heart disease comes with warning signs. But some of the deadliest types, like structural heart disease (SHD), creep in silently. No chest pain. No shortness of breath. Nothing until it's too late. Now, a new artificial intelligence tool called EchoNext is changing the game. It can flag hidden heart problems that even trained cardiologists miss just by analyzing a standard ECG. That's right. A routine, five-minute heart test you've probably already had could now unlock life-saving information if AI is watching. Sign up for my FREE CyberGuy ReportGet my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you'll get instant access to my Ultimate Scam Survival Guide — free when you join my SHD refers to defects in the heart's walls, valves or chambers. Some are present at birth. Others develop slowly over time. Either way, they often go unnoticed until something major happens, like a heart attack or stroke. That's why experts sometimes call SHD the "hidden" heart disease. Here's the problem. Even the ECGs doctors routinely use to spot heart issues often can't detect SHD on their own. And that's where EchoNext comes in. EchoNext was created by researchers at Columbia University and NewYork-Presbyterian. The tool was trained on over 1.2 million ECG and echocardiogram pairs from more than 230,000 patients. Its job? Figure out when a patient's ECG suggests a deeper look is needed, specifically, an echocardiogram, the ultrasound that gives a detailed view of heart structure. "EchoNext basically uses the cheaper test to figure out who needs the more expensive one," explained Dr. Pierre Elias, who led the study. And the results? Stunning. In tests, EchoNext correctly flagged 77% of structural heart disease cases from ECGs. Cardiologists? Just 64%. Even more impressive, when tested on nearly 85,000 people, EchoNext identified over 7,500 at high risk for undiagnosed SHD. A year later, researchers found that 73% of those who followed up with echocardiograms were indeed diagnosed with SHD, a rate far above average. These groundbreaking results were published in Nature, one of the world's most respected scientific journals. That's not just a better test. That's a potential lifesaver. Millions walk around every day with SHD and have no idea. They skip heart screenings because nothing feels wrong. Even when they do get an ECG, subtle warning signs can slip by unnoticed. EchoNext doesn't miss them. And it doesn't get tired or distracted. This isn't about replacing doctors. Iit's about giving them a powerful new tool to catch what humans alone can't. You don't need to wait for symptoms to take your heart health seriously. If you've ever had an ECG, or you're getting one soon, AI could now help spot hidden risks your doctor might miss. Tools like EchoNext make it easier to catch heart problems early, even if you feel fine. This means fewer surprises, fewer missed diagnoses and a better shot at treatment before it's too late. It's not about replacing doctors. It's about giving them, and you, a better shot at catching problems early. Ask your doctor if AI tools are being used to review your heart tests. You deserve every advantage. Right now, EchoNext is being used in research settings, but tools like it are quickly moving toward wider use in hospitals and clinics. AI is no longer the future of medicine. It's happening now. EchoNext proves that machine learning can radically improve how we detect silent killers like SHD. If a simple ECG plus AI could save thousands of lives, what are we waiting for? Would you trust a machine to catch what your cardiologist might overlook? Let us know by writing us at Sign up for my FREE CyberGuy ReportGet my best tech tips, urgent security alerts and exclusive deals delivered straight to your inbox. Plus, you'll get instant access to my Ultimate Scam Survival Guide — free when you join my Copyright 2025 All rights reserved.
